Liquid Biopsy: A New Era in Oncology – How Minimally Invasive Diagnostics Is Transforming Patient Care
We are pleased to invite you to our hybrid symposium, “Liquid Biopsy: A New Era in Oncology – How Minimally Invasive Diagnostics Is Transforming Patient Care”, taking place on March 21, 2026, in Munich.
The event will focus on current developments in precision medicine, with internationally recognized experts offering detailed insights into how minimally invasive molecular testing is transforming patient care. Topics include early cancer detection, real-time treatment monitoring, and personalized treatment decisions, highlighting the latest advances in the analysis of circulating tumor markers such as circulating tumor DNA.
Participants will have the opportunity to exchange ideas with experts and gain state-of-the-art perspectives on the application of liquid biopsy in clinical practice.